Can You Get Allergy Shots? A Four-Pillar Access Guide to Immunotherapy

Finding a board-certified allergist who administers allergy shots starts with the AAAAI provider finder at aaaai.org or the ACAAI physician finder at acaai.org — both allow you to search by location and specialty. Board certification in allergy and immunology requires additional training beyond general internal medicine or pediatrics and is the credential that guarantees expertise in immunotherapy. Verify insurance acceptance by calling the office directly, as online directories sometimes have outdated network information. Ask specifically whether the practice administers allergy shots in-house or refers to a separate injection clinic. Some primary care physicians and ENT practices also administer allergy shots under allergist supervision — expanding the pool of available injection locations beyond allergist offices. Rural areas with no allergist may offer telemedicine allergist consultation for diagnosis and prescription, with injections administered through a local primary care practice under remote allergist oversight.

Without insurance, allergy shots typically cost $1,500 to $4,500 per year during the build-up phase, and $600 to $1,500 per year during maintenance — for a 5-year total of $4,000 to $12,000 depending on geographic location, practice type, and the number of allergens treated. The out-of-pocket cost breaks down into allergen testing (one-time $150-400), allergen extract preparation ($100-300 per vial), and injection administration fees ($25-60 per visit). Academic medical centers and federally qualified health centers (FQHCs) sometimes offer reduced self-pay rates. Some allergy practices offer payment plans. Comparing the 5-year self-pay cost of allergy shots against 5 years of daily antihistamines plus nasal steroids ($1,500-3,000 over 5 years for OTC medications) often makes immunotherapy less financially favorable for self-pay patients unless the disease-modification benefit is factored into the comparison.

Telemedicine allergists can conduct diagnostic consultations, review allergy test results, and in many states prescribe allergen extracts for immunotherapy. Traditionally, telemedicine could not cover the injection itself — that had to be given in a facility equipped to manage anaphylaxis. Today, for eligible maintenance patients, at-home SCIT through Curex makes the shot a telehealth-supported home treatment: a board-certified allergist prescribes a personalized serum sterile-compounded to USP <797> standards, confirms a prescribed epinephrine auto-injector is on hand, and supervises the first injection and every dose change live over Zoom. Where a patient is not an at-home candidate, telemedicine still adds value — remote consultation and treatment planning, with injections given at a local primary care office or clinic under remote allergist supervision. Telemedicine allergists can also prescribe sublingual immunotherapy drops, a separate modality suitable for remote management.

Most allergy shots are administered through board-certified allergist offices, which is the standard of care for immunotherapy initiation, extract formulation, and ongoing monitoring. Some primary care physicians (PCPs) and ENT physicians are trained in allergy shot administration and offer this service in their offices — typically under the guidance of an allergist who designs the extract formula. The practical consideration: a PCP-administered injection program may be more convenient (especially if your PCP is local and your allergist is not) but requires coordination between your PCP and the prescribing allergist. Quality and safety depend on the PCP's training and the clinic's emergency preparedness — both facilities must have epinephrine and staff trained to manage anaphylaxis. For the initial evaluation, allergy testing, and extract prescription, seeing a board-certified allergist is strongly preferred. Ongoing injection administration can sometimes be handled at a more convenient local facility once the protocol is established.

Yes — you can see a board-certified allergist without a primary care doctor referral in most cases. Self-referral to an allergist is possible under most insurance plans (PPO plans almost universally; some HMO plans require a PCP referral first). If your insurance requires a PCP referral, you can often obtain one through a telehealth primary care visit without establishing a full long-term relationship with a specific practice. Urgent care providers and walk-in clinics can also provide initial referrals in some insurance systems. Without insurance, no referral is needed — you can call an allergy practice directly and schedule as a self-pay patient. Medicare beneficiaries can self-refer to allergists accepting Medicare without any gatekeeper requirement under Original Medicare, though Medicare Advantage HMO plans may require PCP referral. The referral process should not be a significant barrier to starting immunotherapy in most clinical situations.

Allergy shots are available and effective for adults of all ages, not just children. While early intervention in childhood has the strongest disease-modification evidence (preventing asthma and new sensitizations), adult immunotherapy produces meaningful symptom reduction and quality of life improvement across all age groups. A study by Bozek et al. (Ann Allergy Asthma Immunol, 2016) demonstrated comparable efficacy and safety in patients 65 and older. Adults aged 18-65 are the most straightforward immunotherapy candidates with the fewest age-related complicating factors. Many adults who start immunotherapy in their 20s-40s after years of pharmacotherapy report dramatic improvements in their seasonal symptoms and reduced medication dependence. The treatment protocol for adults is identical to that for older children — the same build-up and maintenance phases, the same safety requirements, and the same efficacy data apply across adulthood.